These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12429568)

  • 1. Functional consequences of perinatal exposure to 3,4-methylenedioxymethamphetamine in rat brain.
    Kelly PA; Ritchie IM; Quate L; McBean DE; Olverman HJ
    Br J Pharmacol; 2002 Dec; 137(7):963-70. PubMed ID: 12429568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and long-term effects of a single dose of MDMA on aggression in Dark Agouti rats.
    Kirilly E; Benko A; Ferrington L; Ando RD; Kelly PA; Bagdy G
    Int J Neuropsychopharmacol; 2006 Feb; 9(1):63-76. PubMed ID: 16060968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4-methylenedioxymethamphetamine): assessment using quantitative autoradiography.
    Battaglia G; Sharkey J; Kuhar MJ; de Souza EB
    Synapse; 1991 Aug; 8(4):249-60. PubMed ID: 1681594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal exposure to MDMA alters noradrenergic neurodevelopment in the rat.
    Thompson VB; Koprich JB; Chen EY; Kordower JH; Terpstra BT; Lipton JW
    Neurotoxicol Teratol; 2012; 34(1):206-13. PubMed ID: 21978916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype.
    Colado MI; Williams JL; Green AR
    Br J Pharmacol; 1995 Aug; 115(7):1281-9. PubMed ID: 7582557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased responsiveness to MDMA in adult rats treated neonatally with MDMA.
    Piper BJ; Meyer JS
    Neurotoxicol Teratol; 2006; 28(1):95-102. PubMed ID: 16271852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age modulates the long-term but not the acute effects of the serotonergic neurotoxicant 3,4-methylenedioxymethamphetamine.
    Broening HW; Bacon L; Slikker W
    J Pharmacol Exp Ther; 1994 Oct; 271(1):285-93. PubMed ID: 7965726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
    Battaglia G; Yeh SY; O'Hearn E; Molliver ME; Kuhar MJ; De Souza EB
    J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotoxic effects of MDMA ("ecstasy") administration to neonatal rats.
    Meyer JS; Grande M; Johnson K; Ali SF
    Int J Dev Neurosci; 2004; 22(5-6):261-71. PubMed ID: 15380826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R; Kerans A; O'Neill B; Harkin A
    Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) exposure induces long-term alterations in the dopaminergic and serotonergic functions in the rat.
    Galineau L; Belzung C; Kodas E; Bodard S; Guilloteau D; Chalon S
    Brain Res Dev Brain Res; 2005 Feb; 154(2):165-76. PubMed ID: 15707670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonergic neurotoxicity of MDMA (ecstasy) in the developing rat brain.
    Meyer JS; Ali SF
    Ann N Y Acad Sci; 2002 Jun; 965():373-80. PubMed ID: 12105113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain.
    Sanchez V; Camarero J; Esteban B; Peter MJ; Green AR; Colado MI
    Br J Pharmacol; 2001 Sep; 134(1):46-57. PubMed ID: 11522596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated administration of the substituted amphetamine p-methoxyamphetamine produces reductions in cortical 5-HT transporter binding but not 5-HT content, unlike 3,4-methylenedioxyamethamphetamine.
    Callaghan PD; Farrand K; Salem A; Hughes P; Daws LC; Irvine RJ
    Eur J Pharmacol; 2006 Sep; 546(1-3):74-81. PubMed ID: 16925993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo analysis of serotonin clearance in rat hippocampus reveals that repeated administration of p-methoxyamphetamine (PMA), but not 3,4-methylenedioxymethamphetamine (MDMA), leads to long-lasting deficits in serotonin transporter function.
    Callaghan PD; Owens WA; Javors MA; Sanchez TA; Jones DJ; Irvine RJ; Daws LC
    J Neurochem; 2007 Feb; 100(3):617-27. PubMed ID: 17181558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute tryptophan depletion potentiates 3,4-methylenedioxymethamphetamine-induced cerebrovascular hyperperfusion in adult male Wistar rats.
    van Donkelaar EL; Kelly PA; Dawson N; Blokland A; Prickaerts J; Steinbusch HW; Ferrington L
    J Neurosci Res; 2010 May; 88(7):1557-68. PubMed ID: 19998482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDMA- and p-chlorophenylalanine-induced reduction in 5-HT concentrations: effects on serotonin transporter densities.
    Boot BP; Mechan AO; McCann UD; Ricaurte GA
    Eur J Pharmacol; 2002 Oct; 453(2-3):239-44. PubMed ID: 12398910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDMA self-administration in rats: acquisition, progressive ratio responding and serotonin transporter binding.
    Schenk S; Hely L; Lake B; Daniela E; Gittings D; Mash DC
    Eur J Neurosci; 2007 Dec; 26(11):3229-36. PubMed ID: 18005064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paroxetine as an in vivo indicator of 3,4-methylenedioxymethamphetamine neurotoxicity: a presynaptic serotonergic positron emission tomography ligand?
    Scheffel U; Ricaurte GA
    Brain Res; 1990 Sep; 527(1):89-95. PubMed ID: 1980843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.